US WorldMeds acquires Orbus Therapeutics
Enhertu wins EU approval for HER2-positive early breast cancer treatment
Citius Oncology reports growth in LYMPHIR unit shipments to US wholesalers
Cumberland Pharmaceuticals to submit New Drug Application for ifetroban
Lynch Regenerative Medicine's Phase IIb clinical trial of rhPDGF-BB injection cleared by FDA
European Commission approves Novartis' Cosentyx for polymyalgia rheumatica
Edwards Lifesciences wins FDA approval for PASCAL Precision tricuspid repair system
GSK wins US FDA approval for chronic hepatitis B treatment Hibsago
Solventum's combined use of Restrata Matrix and Solventum VAC Therapy receives FDA 510(k) clearance
Viatris' RYZUMVI receives US FDA Approval to treat presbyopia
Omeros receives negative EU opinion on narsoplimab after re-examination
Ionis' TRYNGOLZA recommended for EU approval in severe hypertriglyceridemia